Executive Director
Schroeder Institute for Tobacco Research and Policy Studies

Professor
Department of Health, Behavior and Society
The Johns Hopkins Bloomberg School of Public Health
 
Professor (Adjunct)
Department of Oncology
Georgetown University Medical Center
Lombardi Comprehensive Cancer Center

Overview

David B. Abrams, PhD, is Executive Director of the Schroeder Institute for Tobacco Research and Policy Studies at Legacy. He is also a Professor in the Department of Health, Behavior and Society at the Johns Hopkins Bloomberg School of Public Health and Professor (Adjunct) at Georgetown University Medical Center/Lombardi Comprehensive Cancer Center. Previously, Dr. Abrams directed the Office of Behavioral and Social Sciences Research (OBSSR) at the National Institutes of Health. He holds a B.Sc. (honours) in Computer Science and Psychology from the University of Witwatersrand, South Africa, and a Doctorate in Clinical Psychology from Rutgers University, New Jersey. He has published over 250 scholarly articles. Dr. Abrams is author of The Tobacco Dependence Treatment Handbook: A Guide to Best Practices, a recipient of a book of the year award. He was President of the Society for Behavioral Medicine and received their Distinguished Scientist and Mentorship awards. Dr. Abrams also received the Joseph W. Cullen Memorial Award from the American Society for Preventive Oncology for lifetime contributions to tobacco control.

Dr. Abrams brings scientific expertise at the conceptual, basic, applied, policy and administrative levels. His current focus is on providing scientific leadership in tobacco control from a transdisciplinary perspective. Systems integration is arguably the single most critical missing ingredient needed to maximize the unrealized potential to reduce tobacco use prevalence. Specifically, he explores innovative ways to put what is known into widespread practice and policy to make an efficient impact on the population. He is interested in theory, measures and methods development, and in evaluating implementation research to inform policy across a variety of contexts and modes of delivery. Recently, Dr. Abrams is focusing on the role research can play in informing policies for the regulation of tobacco products by the US Food and Drug Administration. This includes development of a strategic research agenda, convening content area experts, conducting knowledge synthesis and rapidly deploying research projects to address FDA mandates, such as whether mentholated cigarettes should remain on the market, evaluating the safety and consumer perceptions of e-cigarettes and tracking public perceptions of other potential and actual FDA regulations.

Research

Population Assessment of Tobacco and Health (PATH) study

The Schroeder Institute is a subcontractor on a 5-year, multimillion-dollar contract from the National Institute on Drug Abuse (NIDA) and the Food and Drug Administration (FDA) to examine the impact of FDA regulation of tobacco products (Andrew Hyland, Principal Investigator). This nationally representative household survey of roughly 40,000 individuals drawn with address-based sampling will have both cross-sectional and longitudinal components, augmented by additional ad hoc data collection. Sampling will focus on youth, young adults, tobacco users, and racial/ethnic minorities. Areas of specific interest include: 1) dual/poly tobacco use; 2) understanding trends in risk perception; 3) characterizing the natural history of tobacco cessation and relapse; 4) connecting markers of tobacco exposure with disease outcomes; 5) examining the effects of FDA tobacco regulation on changes in risk perceptions and other attitudes associated with use patterns, cessation outcomes, and tobacco-related intermediate endpoints and health outcomes, and; 6) assessing the impact of FDA tobacco regulation on non-tobacco users. The PATH study presents an unprecedented opportunity to closely examine the impact of regulatory authority over tobacco products given to the FDA under the Family Smoking Prevention and Tobacco Control Act of 2009.

Principal Investigator: Andrew Hyland, PhD

SI/Legacy collaborators: David Abrams, PhD, Tom Kirchner, PhD, Ray Niaura, PhD, Jennifer Pearson, PhD, Amanda Richardson, PhD, Donna Vallone, PhD, Andrea Villanti, PhD

Collaborators at other institutions: Michael Cummings, PhD (Medical University of South Carolina); Geoffrey Fong, PhD (University of Waterloo); Andrew Hyland, PhD (Roswell Park Cancer Institute); Karen Messer, PhD (UC San Diego); John Pierce, PhD (UC San Diego); Saul Shiffman, PhD (University of Pittsburg); Jim Sargent, PhD (Dartmouth); Susanne Tanski, MD (Dartmouth); Mitch Zeller, JD (Pinney Associates)

Funding agency: National Institute on Drug Abuse and Center for Tobacco Products at the Food and Drug Administration

Contract number: HHSN271201100027

Project period: 9/18/2011 - 9/18/2016

Understanding how to put evidence-based smoking cessation interventions and policies into practice

Understanding how to put evidence-based smoking cessation interventions and policies into practice

Dr. Abrams has played a leadership role in several initiatives to better understand consumer use behavior, consumer demand, and direct to consumer marketing in an effort to increase impact of smoking cessation services on cessation rates. Some of this ongoing work culminated in a special supplement to the American Journal of Preventive Medicine in March 2010 where Schroeder Institute faculty led five of the papers published. Three of these papers were based on an integrative systems framework and simulation modeling of combined effects of multilevel contexts. The Health and Human Services Secretary Sebelius’ recent report “DHHS Tobacco Control Strategic Plan for the Nation” (Nov 14th, 2010) cited one of these papers as “...the most current and authoritative model of the effect of comprehensive tobacco control measures…” Examples of papers from this supplement include:

  • Orleans CT, Mabry PL, Abrams DB. Increasing Tobacco Cessation in America: A Consumer Demand Perspective. Am J Prev Med. 2010 Mar;38(3 Suppl):S303-S306. PMID: 20176300. No abstract available.
  • Abrams DB, Graham AL, Levy DT, Mabry PL, Orleans CT. Boosting Population Quits Through Evidence-Based Cessation Treatment and Policy. Am J Prev Med. 2010 Mar;38(3 Suppl):S351-63. PMID: 20176308. Abstract.
  • Levy DT, Graham AL, Mabry PL, Abrams DB, Orleans CT. Modeling the impact of smoking-cessation treatment policies on quit rates. Am J Prev Med. 2010 Mar;38(3 Suppl):S364-S372. PMID: 20176309. Full text.
  • Levy DT, Mabry PL, Graham AL, Orleans CT, Abrams DB. Reaching Healthy People 2010 by 2013: A SimSmoke simulation. Am J Prev Med. 2010 Mar;38(3 Suppl):S373-81. PMID: 20176310. Full text.

Examining scientific evidence in support of the Family Smoking Prevention and Tobacco Control Act of 2009

Examining scientific evidence in support of the Family Smoking Prevention and Tobacco Control Act of 2009

Dr. Abrams has spearheaded efforts to examine the extraordinary opportunity for research to support the FDA’s Center for Tobacco Products (CTP) in its effort to regulate tobacco products and protect public health. Ongoing examples of these efforts are as follows: (1) Commissioned expert panels for knowledge synthesis of the evidence related to menthol cigarettes; (2) Executed research and secondary data analysis and conducted simulation modeling to support removal of mentholated cigarettes from the marketplace; (3) Conducted surveys and developed items to examine public awareness/opinions concerning the new FDA regulatory authority and included items to assess consumer sentiment related to various anticipated regulatory changes; (4) Partnered with Georgetown University and Arista Laboratories to examine the product characteristics and the marketing of e-cigarettes; (5) Fielded a nationally-representative survey to obtain baseline data on public attitudes related to FDA tobacco regulation, a menthol ban, reducing nicotine levels in cigarettes, use of e-cigarettes (ENDS) to gain insight into the influence of regulatory activities on consumer knowledge, attitudes and behavior; (6) Established a coalition and a coordinating committee able to quickly involve experts from the tobacco research community to respond rapidly to FDA needs or emerging opportunities. Sample publications from this work are listed below:

  • Tauras JA, Levy D, Chaloupka FJ, Villanti AC, Niaura RS, Vallone DM, Abrams DB. Menthol and non-menthol smoking: the impact of prices and smoke-free air laws. Addiction. 2010 Dec;105 Suppl 1:115-23. PMID: 21059142. Full text.
  • Cobb NK, Byron MJ, Abrams DB, Shields PG. Novel nicotine delivery systems and public health: The rise of the "e-cigarette". Am J Public Health 2010, Dec;100(12):2340-2 100. PMID: 21068414. No abstract available.
  • Levy DT, Pearson JL, Villanti AC, Blackman K, Vallone DM, Niaura RS, Abrams DB. Modeling the future effects of a menthol ban on smoking prevalence and smoking-attributable deaths in the United States. Am J Public Health. 2011 Jul;101(7):1236-40. PMID: 21566034. Abstract.
  • Levy DT, Blackman K, Tauras J, Chaloupka FJ, Villanti AC, Niaura RS, Vallone DM, Abrams DB. Quit attempts and quit rates among menthol and nonmenthol smokers in the United States. Am J Public Health. 2011 Jul;101(7):1241-7. PMID: 21566032. Abstract.
  • Villanti AC, Vargyas EJ, Niaura RS, Beck SE, Pearson JL, Abrams DB. Food and Drug Administration regulation of tobacco: integrating science, law, policy, and advocacy. Am J Public Health. 2011 Jul;101(7):1160-2. PMID: 21566020. FullText.
  • Winickoff JP, McMillen RC, Vallone DM, Pearson JL, Tanski SE, Dempsey JH, Healton C, Klein JD, Abrams DB. US attitudes about banning menthol in cigarettes: Results from a nationally representative survey. Am J Public Health. 2011 Jul;101(7):1234-6. PMID: 21566038. Abstract.

Improving Adherence to Web-Based Cessation Programs: A Social Network Approach

Improving Adherence to Web-Based Cessation Programs: A Social Network Approach

 

Practical counseling, social support, and nicotine replacement therapy (NRT) are components of tobacco dependence treatment that increase the chances of cessation. Web-based interventions are a promising delivery channel for tobacco dependence treatment. Although millions of smokers use the Internet for cessation assistance each year, most users engage only minimally with even the best designed cessation websites, diminishing their impact due to limited exposure/use of effective treatment components (an insufficient “dose”). The goal of this study is to compare the effectiveness of two approaches to improve adherence to the elements of tobacco dependence treatment delivered via the Internet. Addressing adherence to Internet cessation programs is critical and timely to leverage the potential public health impact of this “broad reach” treatment modality. The proposed study is unconventional and innovative in its use of a social network intervention approach to improve both behavioral and pharmacological treatment adherence to enhance cessation outcomes.

Principal Investigator:  Amanda L. Graham, PhD

SI/Legacy Collaborators: Nathan Cobb, MD, David Abrams, PhD, Raymond Niaura, PhD

Collaborators at other institutions: George Papandonatos, PhD (Brown University), Larry An, PhD (University of Michigan)

Funding Agency: National Cancer Institute (1R01CA155489-01A1)

Project Period:  7/2011 – 6/2016

Online Social Networks for Dissemination of Smoking Cessation Interventions

Online Social Networks for Dissemination of Smoking Cessation Interventions

This project seeks to determine the elements of an application for smoking cessation that determine diffusion (viral spread). Based on previous pilot work, we plan to create a smoking cessation application within Facebook where multiple elements can be turned on or off. This allows us to randomize individuals to one of dozens of potential possible applications, and look for effect and interaction effects using a factorial model. The primary outcome of this project is to look at dissemination (as opposed to effectiveness).

Principal Investigator: Nathan K. Cobb, MD

SI/Legacy Collaborators: Amanda Graham, PhD, David Abrams, PhD

Collaborators at other institutions: Nathan Cobb, MD (Georgetown University), Tom Valente, PhD (USC), E. Paul Wileyto, PhD (U Penn), Linda Collins, PhD (Penn State)

Funding Agency: National Cancer Institute (1R01CA155369-01A1)

Project Period: 8/2011 - 6/30/2014

Integrated Applications for Cessation

Integrated Applications for Cessation

This project seeks to develop a set of integrated, online tools for smokers to quit and stay quit, assisted by other individuals in their social environment. The system as envisioned will include a series of interlocking components: access to a social network for support and dissemination, text messaging for proactive content, and IVR and mobile applications for access at any time. This project is funded internally and supplemented with external funding.

Principal Investigator: Nathan K. Cobb, MD

SI/Legacy Collaborators: Amanda Graham, PhD, David Abrams, PhD, Tom Kirchner, PhD

Funding: Internal

Transmission of nicotine dependence, psychiatric, alcohol and substance abuse comorbidity across generations

Transmission of nicotine dependence, psychiatric, alcohol and substance abuse comorbidity across generations

Opportunities are available to conduct additional analyses and work on manuscripts from a rich and extensive dataset housed at the Schroeder Institute. The original study was conducted at The Brown University Transdisciplinary Tobacco Use Research Center (TTURC). It was a retrospective and prospective study of the parents and 2 generations of offspring of the National Collaborative Perinatal Cohort, first sampled from 1959 to 1964 for prospective examination of the effects of in-utero and early childhood environment on psychosocial and school adjustment up to age 7. The sample was re-contacted when offspring were aged about 40. Over 1600 probands were interviewed for retrospective and current behaviors and biological samples were collected for genetic studies. Measures are extensive and include tobacco use behavior, lifetime trajectories of patterns of tobacco use, mental illness/psychiatric and alcohol/substance abuse comorbidity, in-utero exposure during pregnancy, phenotypes. Data were also collected for methodological studies such as assessing reliability, validity and response bias to surveys and household interviews. Ongoing analyses pertain to: the natural history and patterns of smoking trajectories and transitions from uptake to regular use to relapse episodes; tobacco use and comorbid mental illness, alcohol and substance abuse; in-utero exposure to smoking during pregnancy and effects on offspring; and measures of dependence phenotypes to examine genotypes. Sample publications to date include:

  • Abrams DB, Leslie F, Mermelstein R, Kobus K, Clayton RR. Transdisciplinary tobacco use research.  Nicotine Tob Res. 2003 Dec;5 Suppl 1:S5-10. PMID: 14668083. No abstract available.
  • Gilman SE,  Rende R, Boergers J, Abrams DB, Buka SL, Clark MA, Colby SM, Hitsman B, Kazura AN, Lipsitt LP, Lloyd-Richardson EE, Rogers ML, Stanton CA, Stroud LR, Niaura RS. Parental smoking and adolescent smoking initiation: an intergenerational perspective on tobacco control. Pediatrics. 2009 Feb;123(2):e274-81. PMID: 19171580. Full text.
  • Kahler CW, Daughters SB, Leventhal AM, Rogers ML, Clark MA, Colby SM, Boergers J, Ramsey SE, Abrams DB, Niaura R, Buka SL. Personality, psychiatric disorders, and smoking in middle-aged adults. Nicotine Tob Res. 2009 Jul;11(7):833-41. Epub 2009 May 26. PMID: 19470795. Full text.
  • Kahler CW,Leventhal AM, Daughters SB, Clark MA, Colby SM, Ramsey SE, Boergers J, Abrams DB, Niaura R, Buka SL. Relationships of personality and psychiatric disorders to multiple domains of smoking motives and dependence in middle-aged adults. Nicotine Tob Res. 2010 Apr;12(4):381-9. Epub 2010 Feb 18. PMID: 20167635. Full text.
  • Graham AL, Papandonatos GD, DePue JD, Pinto BM, Borrelli B, Neighbors CJ, Niaura R, Buka SL, Abrams DB. Lifetime characteristics of participants and non-participants in a smoking cessation trial: implications for external validity and public health impact. Ann Behav Med. 2008 Jun;35(3):295-307. Epub 2008 Apr 15. PMID: 18414962. Abstract.

Principal Investigators:  David Abrams, PhD, and Raymond Niaura, PhD

SI/Legacy Collaborators: Amanda Graham, PhD

Collaborators at other institutions: Suzanne Colby, PhD (Brown University), Stephen Buka, ScD (Brown University), Christopher Kahler, PhD (Brown University), Melissa Clark PhD, (Brown University), George Papandonatos, PhD (Brown University), Belinda Borrelli, PhD (Brown University), and others.

Funding agency: National Cancer Institute (P50 CA084719)

Project Period:  09/30/2009 – 09/29/2011

A Mixed Methods EMA Assessment of Cognition and Behavior among New e-Cigarette Users

E-cigarettes are the most prevalent of the emerging noncombustible products. Research suggests that African American smokers are less likely than White smokers to try or use e-cigarettes, perhaps due to a greater degree of perceived harm associated with e-cigarettes, a preference for menthol, or cultural norms. However, differential adoption of e-cigarettes by race may not continue as mentholated e-cigarettes are increasingly marketed to African Americans. The goal of this study is to evaluate how all smokers, including African American and menthol smokers, experience and initiate e-cigarette use. Specific aims are: (1) to examine how the immediate environmental and psychological contexts of cigarette and e-cigarette use vary within subjects; (2) to examine how these contexts vary between subjects by menthol preference and race; and (3) to examine participants’ “lived experience” of the meaning, influences, and utility of cigarette and e-cigarette use. To meet these aims, investigators will conduct an observational study involving three weeks of ecological momentary assessment (EMA), two weeks of e-cigarette trial, and in-depth interview data collection, followed by 30-day follow-up telephone contact to assess cigarette and e-cigarettes use. Findings will provide information about the immediate environmental contexts and psychological correlates associated with ENDS initiation in menthol and non-menthol smokers interested in trying ENDS.

Principal Investigator:  Jennifer Pearson, MPH, PhD

SI/Legacy Collaborators: David Abrams, PhD, Thomas Kirchner, PhD

Collaborators at other institutions: Robin Mermelstein, PhD, Don Hedeker, PhD (University of Illinois at Chicago)

Funding agency:  National Institute on Drug Abuse (1R21DA036472-01)

Project Period: 10/2013 – 8/2015

A Mixed Methods EMA Assessment of Cognition and Behavior among New e-Cigarette Users

E-cigarettes are the most prevalent of the emerging noncombustible products. Research suggests that African American smokers are less likely than White smokers to try or use e-cigarettes, perhaps due to a greater degree of perceived harm associated with e-cigarettes, a preference for menthol, or cultural norms. However, differential adoption of e-cigarettes by race may not continue as mentholated e-cigarettes are increasingly marketed to African Americans. The goal of this study is to evaluate how all smokers, including African American and menthol smokers, experience and initiate e-cigarette use. Specific aims are: (1) to examine how the immediate environmental and psychological contexts of cigarette and e-cigarette use vary within subjects; (2) to examine how these contexts vary between subjects by menthol preference and race; and (3) to examine participants’ “lived experience” of the meaning, influences, and utility of cigarette and e-cigarette use. To meet these aims, investigators will conduct an observational study involving three weeks of ecological momentary assessment (EMA), two weeks of e-cigarette trial, and in-depth interview data collection, followed by 30-day follow-up telephone contact to assess cigarette and e-cigarettes use. Findings will provide information about the immediate environmental contexts and psychological correlates associated with ENDS initiation in menthol and non-menthol smokers interested in trying ENDS.

 

Principal Investigator:  Jennifer Pearson, MPH, PhD

SI/Legacy Collaborators: David Abrams, PhD, Thomas Kirchner, PhD

Collaborators at other institutions: Robin Mermelstein, PhD, Don Hedeker, PhD (University of Illinois at Chicago)

Funding agency:  National Institute on Drug Abuse (1R21DA036472-01)

Project Period: 10/2013 – 8/2015

Tobacco Control Publications

In Press

  1. Kirchner TR, Villanti A, Pearson J, Cantrell J, Conway K, Vallone D, Abrams D. Tobacco retail outlet advertising practices and proximity to schools, parks and public housing affect Synar underage sales violations in Washington, D.C. Tob Control. In press.
  2. Villanti AC, Abrams DB, Delnevo CD. Informing policy through tobacco regulatory science: an evolving process. Health Behavior and Policy Review. In press.

2014

  1. Nelson DE, FAupel-Badger J, Phillips S, Belcher B, Chang S, Abrams DB, Kramer BS, White MC, O’Malley M, Varanasi AP, Fabian CJ, Wiest JS, Colditz GA, Hall K, Shields PG, Weitzel JN. Future directions for postdoctoral training in cancer prevention: insights from a panel of experts. Cancer Epidemiol Biomarkers Prev. 2014 March 6. [Epub ahead of print]. PMID: 24604827. Abstract.
  2. Rohsenow DJ, Martin RA, Monti PM, Colby SM, Day AM, Abrams DB, Siota AD, Swift RM. Motivational interviewing versus brief advice for cigarette smokers in residential alcohol treatment. J Subst Abuse Treat. 2014 Mar;46(3):346-55. PMID: 24210533. Abstract.
  3. Kirchner TR, Villanti AC, Cantrell J, Anesetti-Rothermel A, Ganz O, Conway KP, Vallone DM, Abrams DB. Tobacco retail outlet advertising practices and proximity to schools, parks and public housing affect Synar underage sales violations in Washington, DC. Tob Control. 2014 Feb 25. [Epub ahead of print]. PMID: 24570101. Abstract.
  4. Abrams DB.  Promise and peril of e-cigarettes: can disruptive technology make cigarettes obsolete? JAMA. 2014 Jan 8;311(2):135-136. PMID: 24399548. No abstract available.
  5. Abrams DB, Villanti A, Warner, K. The Changing Landscape of Tobacco Control Current Status and Future Directions. Chapter 15 Pages 845 –864 in: U.S. Department of Health and Human Services. The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014. Transcript of the “New Health Risks From Cigarette Smoking” segment on The Diane Rehm Show.

2013

 

  1. Villanti AC, Abrams DB. (2013). Smoking prevention policies and programs. In: Gellman MD, Turner JR, eds. Encyclopedia of Behavioral Medicine: Springer. Part 19, 1822-1825, DOI: 10.1007/978-1-4419-1005-9_348. No abstract available.
  2. Richardson A, Ganz O, Stalgaitis C, Abrams D, Vallone D. Noncombustible tobacco product advertising: how companies are selling the new face of tobacco. Nicotine Tob Res. 2013 Dec 30. [Epub ahead of print]. PMID: 24379146. Abstract.
  3. Graham AL, Chang Y, Fang Y, Cobb NK, Tinkelman DS, Niaura RS, Abrams DB, Mandelblatt JS. Cost-effectiveness of internet and telephone treatment for smoking cessation: an economic evaluation of The iQUITT Study. Tob Control. 2013 Nov;22(6):e11. PMID: 23010696. Abstract.
  4. Niaura R, Pearson JL, Abrams DB. Compensation predicts smoking cessation failure. Psychopharmacology (Berl). 2013 Nov;230(2):261-6. PMID: 23748381. Abstract.
  5. Bock BC, Papandonatos GD, de Dios MA, Abrams DB, Azam MM, Fagan M, Sweeney PJ, Stein MD, Niaura R. Tobacco cessation among low-income smokers: motivational enhancement and nicotine patch treatment. Nicotine Tob Res. 2013 Oct 30. [Epub ahead of print]. PMID: 24174612. Abstract.
  6. Kirchner TR, Cantrell J, Anesetti-Rothermel A, Ganz O, Vallone DM, Abrams DB. Geospatial exposure to point-of-sale tobacco: real-time craving and smoking-cessation outcomes. Am J Prev Med. 2013 Oct;45(4):379-385. PMID: 24050412. Abstract.
  7. Giovino GA, Villanti AC, Mowery PD, Sevilimedu V, Niaura RS, Vallone DM, Abrams DB. Differential trends in cigarette smoking in the USA: is menthol slowing progress? Tob Control. 2013 Sep 27. [Epub ahead of print]. PMID: 23997070. Abstract.
  8. Villanti AC, Jiang Y, Abrams DB, Pyenson BS. A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions. PLoS One. 2013 Aug 7;8(8):e71379. PMID: 23940744. Full text.
  9. Pearson JL, Abrams D, Niaura R, Richardson A, Vallone D. Public support for mandated nicotine reduction in cigarettes. Am J Public Health. 2013 Mar;103(3):562-7. PMID: 23327262. Abstract.
  10. Villanti AC, Giovino GA, Burns DM, Abrams DB. Menthol cigarettes and mortality: Keeping focus on the public health standard. Nicotine Tob Res. Feb 2013;15(2):617-618. PMID: 22990220. No abstract available.
  11. Graham AL, Cha S, Papandonatos GD, Cobb NK, Mushro A, Fang Y, Niaura RS, Abrams DB. Improving adherence to web-based cessation programs: a randomized controlled trial study protocol. Trials. 2013 Feb 17;14:48. PMID: 23414086. Full text.
  12. Richardson A, Graham AL, Cobb NK, Xiao H, Mushro A, Abrams D, Vallone D. Engagement promotes abstinence in a web-based cessation intervention: cohort study. J Med Internet Res 2013 Jan 28;15(1):e14. PMID: 23353649. Full text.

2012

  1. Rath JM, Villanti AC, Abrams DB, Vallone DM. Patterns of tobacco use and dual use in U.S. young adults: the missing link between youth prevention and adult cessation. J Environ Public Health. 2012;2012:679134. PMID: 22666279. Full text.
  2. Kirchner TR, Cantrell J, Anesetti-Rothermel A, Pearson J, Cha S, Kreslake J, Ganz O, Tacelosky M,Abrams D, Vallone D. Individual mobility patterns and real-time geo-spatial exposure to point-of-sale marketing. Proceedings of ACM Wireless Health. 2012. No abstract available.
  3. Clark MA, Rogers ML, Boergers J, Kahler CW, Ramsey S, Saadeh F, Abrams DB, Buka S, Niaura R, Colby SM. Transdisciplinary approach to protocol development for tobacco control research: a case study. Transl Behav Med. 2012 Dec;2(4):431-440. PMID: 24073144. Full text.
  4. Levy DT, Boyle RG, Abrams DB. The role of public policies in reducing smoking: the Minnesota SimSmoke tobacco policy model.  Am J Prev Med. 2012 Nov;43(5 Suppl 3):S179-86. PMID: 23079215. Abstract.
  5. Pearson, J, Richardson, A, Niaura, R, Vallone, D, Abrams, DB. A ban on menthol cigarettes: impacts on public opinion and smokers' intention to quit. Am J Public Health. 2012, Nov;102(11):e107-14. PMID: 22994173. Abstract.
  6. Pearson JL, Richardson A, Niaura RS, Vallone DM, Abrams DB. E-cigarette (ENDS) awareness, use, and harm perceptions in US adults. Am J Public Health. 2012 Sep;102(9):1758-66. PMID: 22813087. Full text.
  7. Cobb NK,Abrams DB. Commentary on Wagener et al. (2012): Laissez-faire regulation: turning back the clock on the Food and Drug Administration and public health. Addiction. 2012 Sep;107(9):1552-4. PMID: 22594851. No abstract available.
  8. Villanti AC, Giovino GA, Barker DC, Mowery PD, Sevilimedu V, Abrams DB. Menthol brand switching among adolescents and young adults in the National Youth Smoking Cessation Survey. Am J Public Health 2012 Jul; 102 (7): 1310-1312. PMID: 22594728. Abstract.
  9. Colby SM, Clark MA, Rogers ML, Ramsey S, Graham AL, Boergers J, Kahler CW, Papandonatos GD, Buka SL, Niaura RS, Abrams DB. Development and reliability of the Lifetime Interview on Smoking Trajectories. Nicotine Tob Res. 2012 Mar;14(3):290-8. PMID: 21994340. Full text.
  10. Rimer BK,Abrams DB.  Present and future horizons for transdisciplinary research. Am J Prev Med. 2012 Feb;42(2):200-1. PMID: 22261218. No abstract available.
  11. Chander G, Stanton C, Hutton HE, Abrams DB, Pearson J, Knowlton A, Latkin C, Holtgrave D, Moore RD, Niaura R. Are smokers with HIV using information and communication technology? Implications for behavioral interventions. AIDS Behav 2012 Feb;16(2):383-8. PMID: 21390537. Full text.

2011

  1. Cobb NK, Graham AL, Byron MJ, Niaura RS, Abrams DB, and Workshop Participants. Online social networks and smoking cessation: a scientific agenda.  J Med Internet Res. 2011 Dec 19;13(4):e119. PMID: 22182518. Full text.
  2. Strong DR, Leventhal AM, Evatt DP, Haber S, Greenberg BD, Abrams D, Niaura R. Positive reactions to tobacco predict relapse after cessation. J Abnorm Psychol. 2011 Nov;120(4):999-1005. PMID: 21574668. Abstract.
  3. Graham AL, Papandonatos GD, Kang H, Moreno JL, Abrams DB. Development and validation of the Online Social Support for Smokers Scale. J Med Internet Res. 2011 Sep 28;13(3):e69. PMID: 21955465. Full text.
  4. Cobb NK,Abrams DB.E-Cigarette or drug-delivery device? Regulating novel nicotine products. N Engl J Med. 2011, Jul 21;365(3):193-5. PMID: 21774706. No abstract available.
  5. Levy DT, Pearson JL, Villanti AC, Blackman K, Vallone DM, Niaura RS,Abrams DB. Modeling the future effects of a menthol ban on smoking prevalence and smoking-attributable deaths in the United States. Am J Public Health. 2011 Jul;101(7):1236-40. PMID: 21566034. Abstract.
  6. Levy DT, Blackman K, Tauras J, Chaloupka FJ, Villanti AC, Niaura RS, Vallone DM, Abrams DB. Quit attempts and quit rates among menthol and nonmenthol smokers in the United States. Am J Public Health. 2011 Jul;101(7):1241-7. PMID: 21566032. Abstract.
  7. Villanti AC, Vargyas EJ, Niaura RS, Beck SE, Pearson JL, Abrams DB. Food and Drug Administration regulation of tobacco: integrating science, law, policy, and advocacy. Am J Public Health. 2011 Jul;101(7):1160-2. PMID: 21566020. Full Text.
  8. Winickoff J, McMillen R, Vallone D, Pearson J, Tanski S, Dempsey J, G Healton C, Klein J, Abrams D. US attitudes about banning menthol in cigarettes: results from a nationally representative survey. Am J Public Health. 2011 Jul;101(7):1234-6. PMID: 21566038. Full text.
  9. Brown RA, Ramsey SE, Kahler CW, Palm KM, Monti PM, Abrams D, Dubreuil M, Gordon A, Miller IW. A randomized controlled trial of cognitive-behavioral treatment for depression versus relaxation training for alcohol-dependent individuals with elevated depressive symptoms. J Stud Alcohol Drugs. 2011 Mar;72(2):286-96. PMID: 21388602. Full text.
  10. Graham AL, Cobb NK, Papandonatos GD, Moreno JL, Kang H, Tinkelman DG, Bock BC, Niaura RS, Abrams DB. A randomized trial of internet and telephone treatment for smoking cessation. Arch Intern Med. 2011 Jan 10;171(1):46-53. PMID: 21220660. Full text.

2010

  1. Villanti AC, McKay HS, Abrams DB, Holtgrave DR, Bowie JV. Smoking-cessation interventions for U.S. young adults: a systematic review. Am J Prev Med. 2010 Dec;39(6):564 –574. PMID: 21084078. Abstract.
  2. Cobb NK, Byron MJ, Abrams DB, Shields PG. Novel nicotine delivery systems and public health: the rise of the "e-cigarette". Am J Public Health 2010, Dec;100(12):2340-2 100. PMID: 21068414. Full text.
  3. Tauras JA, Levy D, Chaloupka FJ, Villanti AC, Niaura RS, Vallone DM, Abrams DB. Menthol and non-menthol smoking: the impact of prices and smoke-free air laws. Addiction. 2010 Dec;105 Suppl 1:115-23. PMID: 21059142. Full text.
  4. Cobb NK, Graham AL, Abrams DB. Social network structure of a large online community for smoking cessation. Am J Public Health 2010, Jul;100(7):1282-9. PMID: 20466971. Abstract.
  5. Levy, DT, Graham AL, Mabry PL, Orleans CT, Abrams, DB. Exploring scenarios to dramatically reduce smoking prevalence: a simulation model of the three-part cessation process. Am J Public Health. 2010 Jul;100(7):1253-9. PMID: 20466969. Full text.
  6. Kahler CW, Leventhal AM, Daughters SB, Clark MA, Colby SM, Ramsey SE, Boergers J, Abrams DB, Niaura R, Buka SL. Relationships of personality and psychiatric disorders to multiple domains of smoking motives and dependence in middle-aged adults. Nicotine Tob Res. 2010 Apr;12(4):381-9. PMID: 20167635. Full text.
  7. Abrams DB, Graham AL, Levy DT, Mabry PL, Orleans CT. Boosting population quits through evidence-based cessation treatment and policy. Am J Prev Med. 2010 Mar;38(3 Suppl):S351-63. PMID: 20176308. Abstract.
  8. Levy DT, Graham AL, Mabry PL, Abrams DB, Orleans CT. Modeling the impact of smoking-cessation treatment policies on quit rates. Am J Prev Med. 2010 Mar;38(3 Suppl):S364-S372. PMID: 20176309. Full text.
  9. Levy DT, Mabry PL, Graham AL, Orleans CT, Abrams DB. Reaching Healthy People 2010 by 2013: A SimSmoke simulation. Am J Prev Med. 2010 Mar;38(3 Suppl):S373-81. PMID: 20176310. Full text.
  10. Orleans CT, Mabry PL,Abrams DB. Increasing tobacco cessation in America: a consumer demand perspective. Am J Prev Med. 2010 Mar;38(3 Suppl):S303-S306. PMID: 20176300. No abstract available.

2009

  1. Magid V, Colder CR, Stroud LR, Nichter M, Nichter M, and the Tobacco Etiology Research Network (TERN - Abrams DBet al.). Negative affect, stress, and smoking in college students: unique associations independent of alcohol and marijuana use. Addict Behav. 2009 Nov;34(11):973-5. PMID: 19523773. Abstract.
  2. Kahler CW, Daughters SB, Leventhal AM, Rogers ML, Clark MA, Colby SM, Boergers J, Ramsey SE, Abrams DB, Niaura R, Buka SL. Personality, psychiatric disorders, and smoking in middle-aged adults. Nicotine Tob Res. 2009 Jul;11(7):833-41. PMID: 19470795. Full text.
  3. Lloyd-Richardson EE, et al. and the Tobacco Etiology Research Network (TERN – Abrams DBet al.). A prospective study of weight gain during the college freshman and sophomore years. Prev Med. 2009 Mar;48(3):256-61. PMID: 19146870. Full text.
  4. Gilman SE, Rende R, Boergers J, Abrams DB, Buka SL, Clark MA, Colby SM, Hitsman B, Kazura AN, Lipsitt LP, Lloyd-Richardson EE, Rogers ML, Stanton CA, Stroud LR, Niaura RS. Parental smoking and adolescent smoking initiation: an intergenerational perspective on tobacco control. Pediatrics. 2009 Feb;123(2):e274-81. PMID: 19171580. Full text.

2008

  1. Graham AL, Papandonatos GD, DePue JD, Pinto BM, Borrelli B, Neighbors CJ, Niaura R, Buka SL, Abrams DB. Lifetime characteristics of participants and non-participants in a smoking cessation trial: implications for external validity and public health impact. Ann Behav Med. 2008 Jun;35(3):295-307. PMID: 18414962. Abstract.
  2. Dierker L, Stolar M, Lloyd-Richardson E, Tiffany S, Flay B, Collins L, Nichter M, Nichter M, Bailey S, Clayton R, and the Tobacco Etiology Research Network (TERN - Abrams Det al.). Tobacco, alcohol, and marijuana use among first-year U.S. college students: a time series analysis. Subst Use Misuse. 2008;43(5):680-99. PMID: 18393083. Full text.

2007

  1. Atienza AA, Hesse BW, Baker TB, Abrams DB, Rimer BK, Croyle RT, Volckmann LN. Critical issues in eHealth research. Am J Prev Med. 2007 May;32(5 Suppl):S71-4. PMID:17466821. Full text.
  2. Brown RA, Niaura R, Lloyd-Richardson EE, Strong DR, Kahler CW, Abrantes AM, Abrams D, Miller IW. Bupropion and cognitive-behavioral treatment for depression in smoking cessation. Nicotine Tob Res. 2007 Jul;9(7):721-30. PMID: 17577801. Full text.

2006 and earlier

  1. Graham AL, Bock BC, Cobb NK, Niaura R, Abrams DB. Characteristics of smokers reached and recruited to an Internet smoking cessation trial: a case of denominators. Nicotine Tob Res. 2006 Dec; 8 Suppl 1:S49-57. PMID: 17491170. Full text.
  2. Graham AL, Bock BC, Cobb NK, Niaura R,Abrams DB. Characteristics of Smokers Reached and Recruited to an Internet Smoking Cessation Trial: A Case of Denominators. Nicotine Tob Res. 2006 Dec; 8 Suppl 1:S49-57. PMID: 17491170. Full text.
  3. Abrams DB. Applying transdisciplinary research strategies to understanding and eliminating health disparities. Health Educ Behav. 2006 Aug;33(4):515-31. PMID: 16769758. Abstract.
  4. Glasgow RE, Green LW, Klesges LM,Abrams DB, Fisher EB, Goldstein MG, Hayman LL, Ockene JK, Orleans CT. External validity: we need to do more. Ann Behav Med. 2006 Apr;31(2):105-8. PMID: 16542124. No abstract available.
  5. Graham AL, Abrams DB. Reducing the cancer burden of lifestyle factors: opportunities and challenges of the Internet. J Med Internet Res. 2005 Jul 1;7(3):e26. PMID: 15998617. Full text.
  6. Cobb NK, Graham AL, Bock BC, Papanonatos G, Abrams DB. Initial evaluation of a "real world" Internet smoking cessation system. Nicotine Tob Res. 2005 Apr;7(2):207-16. PMID: 16036277. Full text.
  7. Bock B, Graham A, Sciamanna C, Krishnamoorthy J, Whiteley J, Carmona-Barros R, Niaura R, Abrams D. Smoking cessation treatment on the Internet: content, quality, and usability. Nicotine Tob Res. 2004 Apr;6(2):207-19. PMID: 15203794. Abstract.
  8. Abrams DB, Leslie F, Mermelstein R, Kobus K, Clayton RR. Transdisciplinary tobacco use research. Nicotine Tob Res. 2003 Dec;5 Suppl 1:S5-10. PMID: 14668083. No abstract available.
  9. Abrams DB, Herzog TA, Emmons KM, Linnan L. Stages of change versus addiction: a replication and extension. Nicotine Tob Res. 2000 Aug;2(3):223-9. PMID: 11082822. Abstract.
  10. Abrams DB, Mills S, Bulger D. Challenges and future directions for tailored communication research. Ann Behav Med. 1999 Fall;21(4):299-306. PMID: 10721436. Abstract.
  11. Abrams DB. Nicotine addiction: paradigms for research in the 21st century. Nicotine Tob Res. 1999;1 Suppl 2:S211-5. PMID: 11768182. No abstract available.
  12. Abrams DB, Orleans CT, Niaura RS, Goldstein MG, Prochaska JO, Velicer W. Integrating individual and public health perspectives for treatment of tobacco: a combined stepped care and matching model. Ann Behav Med. 1996 Fall;18(4):290-304. PMID: 18425675. Abstract.
  13. Abrams DB, Biener L. Motivational characteristics of smokers: a public health challenge. Prev Med. 1992 Nov;21(6):679-87. PMID: 1438114. Abstract.
  14. Lichtenstein E, Glasgow RE, Abrams DB. Social support in smoking cessation: in search of effective interventions. Beh Therapy. 17(5): 607-19. Abstract.

Presentations

    Scientific Meetings

    • Kirchner TR,  Cantrell J, Anesetti-Rothermel A,  Pearson J, Ganz O, Kreslake J,  Vallone D,Abrams DB. Real –Time Geo-Spatial Exposure to Point-of-Sale tobacco marketing predicts daily smoking status during smoking cessation. Society for Research on Nicotine & Tobacco (SRNT), Boston, MA, March 2013.
    • Kirchner TR,  Cantrell J, Anesetti-Rothermel A,  Pearson J, Ganz O, Kreslake J,  Vallone D,Abrams DB. Real- time measures of craving and Exposure to point-of-sale tobacco predict outcomes during smoking cessation. Society for Research on Nicotine & Tobacco (SRNT), Boston, MA, March 2013.
    • Pearson J, Fang Y, Vallone D,Abrams DB, Niaura R. A critical examination of the relationships between intention to quit, quit attempts, and cessation. Society for Research on Nicotine & Tobacco (SRNT), Boston, MA, March 2013.
    • Pearson J, Feirman S,Abrams DB, Hassmiller Lich K. A system dynamics models of the effect of e-cigarette price on current and former smokers’ tobacco use behavior. American Academy of Health Behavior (AAHB), Santa Fe, NM, March 2013.
    • Shiffman S, et al &Abrams DB. Discussant.  Ecological Momentary Assessment of Smoking: Capturing Microprocesses Across the Tobacco Use Life-Cycle. Society for Behavioral Medicine (SBM), San Francisco, CA, March 2013.

    Invited Presentations

    • Abrams DBSpeaker.Tobacco Policy Modeling Workshop: The Big Picture: Potential for Tobacco Policy Modeling, Including Questions of Dual Use. Rockville, MD, January, 2013.
    • Abrams DBLecturer.Georgetown University, TBIO-520: Introduction to Epidemiology, Prevention, and Cancer Control.Washington, DC, February, 2013.
    • Abrams DB. Speaker. Georgetown University. Grand Rounds, Washington, DC, February, 2013.
    • Abrams DB.Speaker.Webinar: Coalitions Kicking Butts: Tobacco Control Policy Approaches. Washington, DC, February, 2013.
    • Abrams DB etTercyak KP. Speaker. Georgetown University CERSI Research Day:The Schroeder Institute, Georgetown Lombardi, and Georgetown CERSI: Embracing Regulatory Science to Advance Tobacco Control Product Regulation.Silver Spring, MD, March, 2013.
    • Abrams DB.Speaker. Georgetown University CERSI Research Day: Challenges and Opportunities to Reduce Tobacco Harms Through Robust Regulatory Science.Silver Spring, MD, March, 2013.
    • Abrams DB.Lecture. Johns Hopkins School of Public Health.Tobacco Control Research to inform FDA policy implementation, Baltimore, MD, April 2013.
    • Abrams DB.Lecture. Johns Hopkins School of Public Health.Policy Interventions for Health Behavior Change, Baltimore, MD, May 2013.
    • Abrams DB.Speaker. Luncheon and the William H. Sorrell Lecture Series on Tobacco Policy and Enforcement. Boston, MA, June, 2013.
    • Abrams DB.TPSAC/Risk Communication Advisory Committee and Tobacco products Scientific Advisory Committee Joint Meeting, Silver Spring, MD, August 2013.
    • Abrams DB.Speaker. CDC listening session, Re: Electronic Cigarette and Nicotine Reduction Expert Panel Meeting. Atlanta, Georgia, August, 2013.

    e-Cigarettes (ENDS): Benefits and Concerns to Reduce the Harms of (Combusted?) Tobacco Use Behavior

    Download the Presentation